Enveric Biosciences Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$1.31

-0.04 (-2.96%)

As of Jun 24, 10:18 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +656.5% upside

Low Target $5.56

Average Target $9.91

High Target $13.09

Current Price $1.31

Current
$1.31

Target
$9.91

$5.56 $9.91 avg $13.09

Scenario Analysis

Bear Case

$5.56

324.4%

Low target

Base Case

$9.91

+656.5%

Avg target

Bull Case

$13.09

+899.2%

High target

Risk/Reward

2.8x

Favorable

Price in Context

52-Week High

$17.64

-92.6% from high

52-Week Low

$1.26

+4.0% from low

Target vs 52W High

$9.91

-43.8% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	79%	$1,330.33	+19.1%
RDY Dr. Reddy's Laboratories	Sell	44	50%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	68%	$299.55	+24.3%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+32.1%
PFE Pfizer Inc.	Hold	36	42%	$33.90	+41.0%
BMY Bristol-Myers Squibb Co	Hold	36	39%	$174.50	+217.3%
ZTS Zoetis Inc	Buy	24	58%	$209.87	+168.5%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-33.2%